Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Novavax Names John C. Jacobs as New President & Chief Executive Officer
Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, […]
Ionis and Royalty Pharma Enter Into Royalty Agreement for Up to $1.1 billion
Ionis Pharmaceuticals and Royalty Pharma plc today announced that Royalty Pharma has acquired an interest […]
SoniVie Raises $60m in Round C Financing and Appoints New Board Members
SoniVie, a medical device company developing a proprietary solution to treat hypertension, announced today the […]
Prokarium and Ginkgo Bioworks Announce Partnership to Discover Multiple Targets for RNA Therapeutics and Immuno-oncology
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, and Ginkgo Bioworks, which […]
Astrea Bioseparations acquires Delta Precision, a leading manufacturer of chromatography columns for biomanufacturing
Astrea Bioseparations, a leading provider of high-quality bioseparation and purification technologies, has announced the acquisition […]
Huma to Provide Best-in-class Digital Clinical Trials Solutions Through Landmark Acquisition of Alcedis
Huma Therapeutics, a leading global digital health company, today announced that it has acquired Alcedis […]
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences today announced they have entered into a strategic collaboration and licensing […]
Phio Pharmaceuticals Announces Regulatory Clearance of Clinical Trial to Treat Solid Tumors
Phio Pharmaceuticals has announced their clinical development partner, AgonOx, has received confirmation from the FDA […]
Amolyt Pharma Announces $138 Million Series C Financing
Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related […]
Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria
Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more